Modella AI and AstraZeneca link for cancer clinical development
Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development. The partnership will give AstraZeneca…
News
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer
Big pharma braces for revenue headwinds as patent expiries loom
Biocon’s Denosumab biosimilars gain EU marketing authorisation
Brii Biosciences and Joincare sign licence agreement for BRII-693
Theratechnologies shares surge 25% amid $254m Future Pak takeover
UK Government reveals 10-year plan for NHS
BioVersys and Shionogi agree to develop ansamycin leads
